UB Paderborn / Katalog / Suche / in CDI

Thrombotic Events in Patients With Cancer Receiving Antiangiogenesis Agents

Journal of clinical oncology, 2009-10, Vol.27 (29), p.4865-4873

2009

Link zum Volltext

Verfügbarkeit prüfen

The effect of dabigatran on select specialty coagulation assays

American journal of clinical pathology, 2013-01, Vol.139 (1), p.102-109

2013

Link zum Volltext

Verfügbarkeit prüfen

Chromogenic factor VIII activity assay

American journal of hematology, 2014-07, Vol.89 (7), p.781-784

2014

Link zum Volltext

Verfügbarkeit prüfen

Phenotypic correction of murine hemophilia A using an iPS cell-based therapy

Proceedings of the National Academy of Sciences - PNAS, 2009-01, Vol.106 (3), p.808-813

2009

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2019-09, Vol.17 (9), p.1555-1561

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparison of anti-Xa and dilute Russell viper venom time assays in quantifying drug levels in patients on therapeutic doses of rivaroxaban

Archives of pathology & laboratory medicine (1976), 2014-12, Vol.138 (12), p.1680-1684

2014

Link zum Volltext

Verfügbarkeit prüfen

Quality standards for sample processing, transportation, and storage in hemostasis testing

Seminars in thrombosis and hemostasis, 2012-09, Vol.38 (6), p.576

2012

Link zum Volltext

Verfügbarkeit prüfen

Pre-analytical Variables in Coagulation Testing Associated With Diagnostic Errors in Hemostasis

Laboratory medicine, 2012-02, Vol.43 (2), p.1-10

2012

Link zum Volltext

Verfügbarkeit prüfen

2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

Thrombosis and haemostasis, 2021-08, Vol.121 (8), p.1008

2021

Link zum Volltext

Verfügbarkeit prüfen

An update on laboratory assessment for direct oral anticoagulants (DOACs)

International journal of laboratory hematology, 2019-05, Vol.41 (S1), p.33-39

2019

Link zum Volltext

Verfügbarkeit prüfen

Factor V Leiden-independent activated protein C resistance: Communication from the plasma coagulation inhibitors subcommittee of the International Society on Thrombosis and Haemostasis Scientific and Standardisation Committee

Journal of thrombosis and haemostasis, 2023-01, Vol.21 (1), p.164-174

2023

Link zum Volltext

Verfügbarkeit prüfen

Influence of centrifuge brake on residual platelet count and routine coagulation tests in citrated plasma

Blood coagulation & fibrinolysis, 2014-04, Vol.25 (3), p.292-295

2014

Link zum Volltext

Verfügbarkeit prüfen

Coagulation assays and anticoagulant monitoring

Hematology, 2012-12, Vol.2012, p.460-465

Funk, Dorothy M Adcock

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical utility and impact of the use of the chromogenic vs one‐stage factor activity assays in haemophilia A and B

European journal of haematology, 2020-01, Vol.104 (1), p.3-14

2020

Link zum Volltext

Verfügbarkeit prüfen

Critical pre-examination variables in the hemostasis laboratory and their quality indicators

Clinical biochemistry, 2016-12, Vol.49 (18), p.1315-1320

2016

Link zum Volltext

Verfügbarkeit prüfen

Factor VIII Activity and Inhibitor Assays in the Diagnosis and Treatment of Hemophilia A

Seminars in thrombosis and hemostasis, 2017-04, Vol.43 (3), p.320

2017

Link zum Volltext

Verfügbarkeit prüfen

International Council for Standardization in Haematology Field Study Evaluating Optimal Interpretation Methods for Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies

Archives of pathology & laboratory medicine (1976), 2023-11

2023

Link zum Volltext

Verfügbarkeit prüfen

Performance of coagulation tests in patients on therapeutic doses of rivaroxaban. A cross-sectional pharmacodynamic study based on peak and trough plasma levels

Thrombosis and haemostasis, 2014-06, Vol.111 (6), p.1133

2014

Link zum Volltext

Verfügbarkeit prüfen

Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art

Seminars in thrombosis and hemostasis, 2023-09, Vol.49 (6), p.571

2023

Link zum Volltext

Verfügbarkeit prüfen

Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis?

Seminars in thrombosis and hemostasis, 2008-10, Vol.34 (7), p.612

2008

Link zum Volltext

Verfügbarkeit prüfen

Thrombophilia Testing and Venous Thrombosis

The New England journal of medicine, 2017-12, Vol.377 (23), p.2297-2298

2017

Link zum Volltext

Verfügbarkeit prüfen

Blood collection tubes as medical devices: The potential to affect assays and proposed verification and validation processes for the clinical laboratory

Clinical biochemistry, 2016-12, Vol.49 (18), p.1321-1330

2016

Link zum Volltext

Verfügbarkeit prüfen

Heparin-Calibrated Chromogenic Anti-Xa Activity Measurements in Patients Receiving Rivaroxaban: Can This Test Be Used to Quantify Drug Level?

The Annals of pharmacotherapy, 2015-07, Vol.49 (7), p.777

2015

Link zum Volltext

Verfügbarkeit prüfen

Laboratory Assessment of Hemostatic and Anticoagulant Therapy

Seminars in thrombosis and hemostasis, 2017-04, Vol.43 (3), p.242

2017

Link zum Volltext

Verfügbarkeit prüfen

International Council for Standardization in Haematology (ICSH) recommendations for processing of blood samples for coagulation testing

International journal of laboratory hematology, 2021-12, Vol.43 (6), p.1272-1283

2021

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Thrombotic Events in Patients With Cancer Receiving Antiangiogenesis Agents

The effect of dabigatran on select specialty coagulation assays

Chromogenic factor VIII activity assay

Phenotypic correction of murine hemophilia A using an iPS cell-based therapy

Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH

Comparison of anti-Xa and dilute Russell viper venom time assays in quantifying drug levels in patients on therapeutic doses of rivaroxaban

Quality standards for sample processing, transportation, and storage in hemostasis testing

Pre-analytical Variables in Coagulation Testing Associated With Diagnostic Errors in Hemostasis

2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

An update on laboratory assessment for direct oral anticoagulants (DOACs)

Factor V Leiden-independent activated protein C resistance: Communication from the plasma coagulation inhibitors subcommittee of the International Society on Thrombosis and Haemostasis Scientific and Standardisation Committee

Influence of centrifuge brake on residual platelet count and routine coagulation tests in citrated plasma

Coagulation assays and anticoagulant monitoring

Clinical utility and impact of the use of the chromogenic vs one‐stage factor activity assays in haemophilia A and B

Critical pre-examination variables in the hemostasis laboratory and their quality indicators

Factor VIII Activity and Inhibitor Assays in the Diagnosis and Treatment of Hemophilia A

International Council for Standardization in Haematology Field Study Evaluating Optimal Interpretation Methods for Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies

Performance of coagulation tests in patients on therapeutic doses of rivaroxaban. A cross-sectional pharmacodynamic study based on peak and trough plasma levels

Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art

Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis?

Thrombophilia Testing and Venous Thrombosis

Blood collection tubes as medical devices: The potential to affect assays and proposed verification and validation processes for the clinical laboratory

Heparin-Calibrated Chromogenic Anti-Xa Activity Measurements in Patients Receiving Rivaroxaban: Can This Test Be Used to Quantify Drug Level?

Laboratory Assessment of Hemostatic and Anticoagulant Therapy

International Council for Standardization in Haematology (ICSH) recommendations for processing of blood samples for coagulation testing

Suchergebnisse filtern